Stelara 130 MG/26 ML vial 26ML

Ended Awarded

Contract number
SPE2DB24FYW52
Awardee
Awarding agency
Obligated
$16,166

Award facts

Contract value 100% obligated
$16,165.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Stelara 130 mg/26 ml vials. The $16,165.76 contract has an ultimate completion date of April 16, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract (SPE2DB24FYW52) with DLA, valued at up to $4,999,999 through 2025, for the provision of a broad range of pharmaceutical products to military health facilities worldwide. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FYW52?

SPE2DB24FYW52 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 26, 2024.

How much is contract SPE2DB24FYW52 worth?

The government has obligated $16,166 on SPE2DB24FYW52.

Is contract SPE2DB24FYW52 an order under another contract?

Yes. SPE2DB24FYW52 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.

Was contract SPE2DB24FYW52 competed?

The extent of competition for SPE2DB24FYW52 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login